Factor V Leiden in Greek thrombophilic patients: Relationship with activated protein C resistance test and levels of thrombin-antithrombin complex and prothrombin fragment 1+2

Blood Coagulation and Fibrinolysis

Volumn 8, Issue 8, 1997, Pages 485-489

  Lambropoulos, A F ^a   Foka, Z ^a   Makris, M ^b   Daly, M ^b   Kotsis, A ^a   Makris, P E ^c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

APC r test; F1+2; Factor V Leiden; TAT

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5; PROTHROMBIN; THROMBIN;

ADULT; ARTICLE; BLOOD CLOTTING TEST; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THROMBOPHILIA;

EID: 0031454356     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199711000-00001     Document Type: Article

References (28)

1. Svensson P, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522.
2. Vorberg J, Roelse J, Koopman R, Buller H, Beremds F, ten Cate J, et al. Association of idiopathic venous thromboembolism with single point-mutation at Arg 506 of factor V. Lancet 1994; 343: 1535-1536.
3. Zoller B, Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994; 343: 1536-1538.
4. Greengard J, Eichinger S, Griffin J, Bauer A. Variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg6G1n mutation in the gene for factor V. N Engl J Med 1994; 339: 1559-1562.
5. Bertina R, Koeleman B, Koster T, Rosendaal F, Dirven R, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
6. Engel H, Zwang L, van Vilet HHDM, Michiels JJ, Stibbe J, Lindermans J. Phenotyping and genotyping of coagulation factor V Leiden. Thromb Haemost 1996; 75: 267-269.
7. Dahlbäck B, Carlsson M, Svensson P. Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008.
8. Dahlbäck B, Kildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 1994; 91: 1396-1400.
9. Koster T, Rosendaal F, de Ronde H, Briet E, Nanderbroucke J, Bertina R. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993; 342: 1503-1506.
10. Leroy-Matheron C, Levent M, Pignon JM, Mendonca C, Goualt-Heilmann M. The 1691 G6A mutation in the factor V Gene: relationship to activated protein C (APC) resistance and thrombosis in 65 patients. Thromb Haemost 1996; 75: 4-10.
11. Rees D, Cox M, Clegg J. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134.
12. Majerus PW. Bad blood by mutation. Nature 1994; 369: 14-15.
13. Dahlbäck B. Resistance to activated protein C: the Arg 506 to Gln mutation in the factor V gene, and venous thrombosis. Thromb Haemost 1995; 73: 739-742.
14. de Ronde, Bertina R. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994; 72: 880-886.
15. Trossaert M, Conard J, Horrelou M, Samama M, Ireland H, Bayston T, et al. Modified APC resistance assay for patients on oral anticoagulants. Lancet 1994; 344: 1709.
16. Jorquera J, Montoro J, Fernandez A, Aznar J. Modified test for activated Protein C resistance. Lancet 1993; 343: 1162.
17. Sun X, Evatt B, Griffin J. Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia. Blood 1994; 83: 3120-3125.
18. Zoller B, Holm J, Svensson P, Dahlbäck B. Elevated levels of prothrombin activation fragment 1+2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency. Thromb Haemost 1996; 75: 270-274.
19. Stirling D, White A, Clarkson J Stewart A, Ludham CA. A comparison between functional and genetic testing for activated protein C resistance (APCR). Blood Coag Fibrinol 1995; 6: 154 (abstract).
20. Borg JY, Beufe C, Vasse M, Monconduit M, Frebourg T. Relations risque thrombotique-phenotype-genotype, dans une grande famille avec facteur V Leiden [in French]. Proc Congr Angio Geneve 1994: 106 (abstract).
21. Zoller B, Svensson PJ, HeX, Dahlbäck B. Identification of the same factor V mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521-2524.
22. Tsakiris DA, Yasikoff ML, Wolf F, Marbet GA. Anticardiolipin antibodies do not seem to be associated with APC resistance in vivo or in vitro. Ann Hematol 1995; 71: 195-198.
23. Cooper PC, Hampton KK, Makris M, Avuzenacah A, Paul B, Preston FE. Further evidence that activated protein C resistance can be misdiagnosed as inherited functional protein S deficiency. Br J Haem 1994; 88: 201-203.
24. Dahlbäck B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 1995; 85: 607-614.
25. Kalafatis M, Bertina R, Rand M, Mann K. Characterisation of factor V from APC-resistant patients homozygous for the Arg506 → Gln mutation. Thromb Haemost 1995; 73: 1362 (abstract).
26. Beuchamp N, Daly M, Hampton K, Cooper P, Preston FE. High prevalence of a mutation in the factor V gene within the UK population: relationship to activated protein C resistance and familial thrombosis. Br J Haematol 1994; 88: 219-222.
27. EGD Tuddenham. Thrombophilia: the new factor is old factor V. Lancet 1994; 343: 1515-1516.
28. Scarano L, Simioni P, Gavasso S, Sardella C, Rossi L, Scudeller A, et al. F1+2 and TAT levels in patients with inherited APC-resistance. Thromb Haemost 1995; 73: 1366 (abstract).